C
Charles W. Kimbrough
Researcher at The Ohio State University Wexner Medical Center
Publications - 23
Citations - 403
Charles W. Kimbrough is an academic researcher from The Ohio State University Wexner Medical Center. The author has contributed to research in topics: Hyperthermic intraperitoneal chemotherapy & Survival rate. The author has an hindex of 9, co-authored 23 publications receiving 292 citations. Previous affiliations of Charles W. Kimbrough include University of Minnesota & Ohio State University.
Papers
More filters
Journal ArticleDOI
Age-Dependent Differences in Survival after Severe Burns: A Unicentric Review of 1,674 Patients and 179 Autopsies over 15 Years
Clifford T. Pereira,Clifford T. Pereira,Robert E. Barrow,Robert E. Barrow,Albert M. Sterns,Albert M. Sterns,Hal K. Hawkins,Hal K. Hawkins,Charles W. Kimbrough,Marc G. Jeschke,Marc G. Jeschke,Jong O. Lee,Jong O. Lee,Arthur P. Sanford,Arthur P. Sanford,David N. Herndon,David N. Herndon +16 more
Journal ArticleDOI
Lymphadenectomy for Intrahepatic Cholangiocarcinoma: Has Nodal Evaluation Been Increasingly Adopted by Surgeons over Time?A National Database Analysis
Xu-Feng Zhang,Qinyu Chen,Charles W. Kimbrough,Eliza W. Beal,Yi Lv,Jeffery Chakedis,Mary Dillhoff,Carl Schmidt,Jordan M. Cloyd,Timothy M. Pawlik +9 more
TL;DR: Overall utilization of LND in the surgical management of ICC across the USA remained relatively low and did not change over the last decade, as well as temporal trends, which may be problematic as T-stage was not a reliable predictor of nodal status.
Journal ArticleDOI
The impact of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio among patients with intrahepatic cholangiocarcinoma.
Stefan Buettner,Gaya Spolverato,Charles W. Kimbrough,Sorin Alexandrescu,Hugo Marques,Jorge Lamelas,Luca Aldrighetti,T. Clark Gamblin,Shishir K. Maithel,Carlo Pulitano,Matthew J. Weiss,Todd W. Bauer,Feng Shen,George A. Poultsides,J. Wallis Marsh,Jan N. M. IJzermans,Bas Groot Koerkamp,Timothy M. Pawlik +17 more
TL;DR: Elevated neutrophil‐to‐lymphocyte ratio was independently associated with worse overall survival and improved the prognostic estimation of long‐term survival among patients with intrahepatic cholangiocarcinoma undergoing resection.
Journal ArticleDOI
Perioperative complications and the cost of rescue or failure to rescue in hepato-pancreato-biliary surgery.
Qinyu Chen,Eliza W. Beal,Charles W. Kimbrough,Fabio Bagante,Katiuscha Merath,Mary Dillhoff,Carl Schmidt,Susan White,Jordan M. Cloyd,Timothy M. Pawlik +9 more
TL;DR: There is a significant cost associated with both rescue and failure-to-rescue from perioperative complications after hepato-pancreato-biliary surgery, and total hospitalization cost was highest for patients who experienced failure to rescue.
Journal ArticleDOI
Should We Be Doing Cytoreductive Surgery with HIPEC for Signet Ring Cell Appendiceal Adenocarcinoma? A Study from the US HIPEC Collaborative
Nick C. Levinsky,Mackenzie C. Morris,Koffi Wima,Jeffrey J. Sussman,Syed A. Ahmad,Jordan M. Cloyd,Charles W. Kimbrough,Keith Fournier,Andrew G. Lee,Sean P. Dineen,Sophie Dessureault,Jula Veerapong,Joel M. Baumgartner,Callisia N. Clarke,Mohammad Y. Zaidi,Charles A. Staley,Shishir K. Maithel,Jennifer L. Leiting,Travis E. Grotz,Laura A. Lambert,Ryan J. Hendrix,Sean M. Ronnekleiv-Kelly,Courtney Pokrzywa,Mustafa Raoof,Oliver S. Eng,Fabian M. Johnston,Jonathan B. Greer,Sameer H. Patel +27 more
TL;DR: While signet cells are a negative prognostic feature, they should not be a contraindication to CRS-HIPEC in patients with well-moderately differentiated tumors with negative lymph nodes, where complete cytoreduction can be achieved.